4//SEC Filing
DEXCOM INC 4
Accession 0001093557-17-000065
$DXCMCIK 0001093557operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:49 PM ET
Size
13.8 KB
Accession
0001093557-17-000065
Insider Transaction Report
Form 4
DEXCOM INCDXCM
LISTER JOHN
VP, Legal Affairs
Transactions
- Exercise/Conversion
Common Stock
2017-03-09$8.85/sh+3,000$26,550→ 96,732 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-03-09$77.67/sh−3,000$233,002→ 10,939 totalExercise: $8.85From: 2009-01-14Exp: 2018-01-14→ Common Stock (3,000 underlying) - Sale
Common Stock
2017-03-09$77.67/sh−3,000$233,002→ 93,732 total - Award
Common Stock
2017-03-08$0.00/sh+23,134$23→ 93,732 total - Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−6,161$477,789→ 87,571 total - Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−3,537$274,296→ 84,034 total
Footnotes (5)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- [F2]Included in this number are 67,634 unvested restricted stock units, 23,134 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019 and 12,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
- [F3]On December 13, 2016, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F4]This transaction was executed in multiple trades at prices ranging from $77.19 to $78.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F5]These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093557
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:49 PM ET
- Size
- 13.8 KB